Mission Statement:

To improve the care and outcomes of kidney disease
patients worldwide through promoting coordination,
collaboration and integration of initiatives to develop
and implement clinical practice guidelines.

Home

Treatment of Infection of the Vascular Access – Central Vein Catheters

Guideline Organization

Recommendation (Evidence Level)

Evidence

Comments

CARI-Australia
2000

a) Presentation with tunnel infection or bacteraemia/septicaemia will require removal of the central line after 48-72 hrs of antibiotics and being afebrile (Level C)
b) Positive blood cultures for S aureus: 2 weeks IV antibiotics or on the advice of the microbiologist (Level B)
c) Avoid vancomycin empirically unless in recognized MRSA or in MRSA carriers (Level B)
d) When exit-site and tunnel not infected, catheter replacement over guidewire under antibiotic (Level B)

Dialysis Guidelines. Vascular access
20. Managing infection in haemodialysis catheters

 

CSN-Canada
2006

- Treat central venous catheter-related bacteremia with systemic antibiotics and catheter exchange over a wire. (Grade D)
- Treat catheter tunnel infections without bacteremia with parenteral antibiotics and appropriate local measures. Catheter removal is indicated if the infection fails to respond to 2 wk of therapy. (Grade D)

Guideline Chapter 4 – Managing VA Complications
PDF: Pg 20 of 27








EBPG-Europe
November 2002

- Non-tunneled short-term catheter should be removed and cultured (Level C)
- Tunneled catheters should be treated for 2-4 weeks (4 wks for bactaeremia) (Level C)
- Catheters to be removed with tunnel infection or infection for > 36 h
- If catheter not removed despite bactaeremia, 2 weeks antibiotic lock after each dialysis in conjunction with parenteral therapy (Level C)
VI.4.4.
- Two separate blood cultures before start antibiotics for all access related infection (Level B)
- Methicillin first choice Glycopeptide recommended in hospitals and countries with increased incidence of MRSA and in known MRSA carriers (Level A)
- Additional coverage for gram-negatives including pseudomonas with third or fourth generation cephalosporins in severely ill and immunocompromised patients (Level B)

VI.4 Treatment of vascular access infection

 

KDOQI-US
2006

7.4 Treatment of an infected HD catheter or port should be based on the type and extent of infection.

  • 7.4.1 All catheter-related infections, except for catheter exit-site infections, should be addressed by initiating parenteral treatment with an antibiotic(s) appropriate for the organism(s) suspected. (A)
  • 7.4.2 Definitive antibiotic therapy should be based on the organism(s) isolated. (A)
  • 7.4.3 Catheters should be exchanged as soon as possible and within 72 hours of initiating antibiotic therapy in most instances, and such exchange does not require a negative blood culture result before the exchange. (B) Follow-up cultures are needed 1 week after cessation of antibiotic therapy (standard practice).
  • 7.4.4 Port pocket infections should be treated with systemic antibiotics and irrigation, in conjunction with the manufacturers' recommendations. (B)

Vascular Access: 7.4 Treatment and Prevention of CV and Port Complications



UK-Guidelines
2007

- Peripheral and central line blood cultures should be taken prior to starting antibiotics in all cases of suspected catheter-related infection.

Module 3a: Haemodialysis- 7.0 Vascular Access